were shown to be primarily composed of short truncated derivatives of mhtt, raising the possibility that proteolytic cleavage of htt plays a key role in pathogenesis. Several other observations support this hypothesis. First, the expression of a truncated mhtt fragment corre- 
Using a panel of anti-htt antibodies in immunofluoresdifferentiated cells expressing T-hd122 instead of FLhd116, as the frequency of aggregates is higher with cence (IF) analysis, we show that in htt-expressing cells and also in HD brain, NIs and cytoplasmic inclusions
truncated forms (Lunkes and Mandel, 1998) . Among the CIs visualized by Abs 1259 or M2, 93% were positive (CIs) are made up of N-terminal htt fragments differing in length. Three independent methods were employed to with mAb 1H6, while only 57% were stained with pAb 214, whose epitope is located more C-terminal (Table  characterize the 2, first, third, and fourth rows), whereas some 1259-To overcome the lack of suitable antibodies directed positive CIs were costained with mAb 1H6 (Figure 2 , to this domain, we generated the construct T-hd73-HA second row). We thus conclude that NIs of HD brain are in which an HA-tag epitope was introduced at position composed of htt fragments proteolysed N-terminal to aa 82 of htt ( Figure 1A ). We first confirmed in a double the epitope of mAb 1H6. The composition of CIs, in IF experiment that NIs formed in differentiated cells excontrast, is heterogeneous, with some CIs bearing the pressing T-hd73-HA were costained with pAb 1259 and epitope of mAb 1H6 and some not. These in situ obseran anti-HA mAb ( Figure 1B, fourth row) some is one of the most important degradation machinsion. As these distinct breakdown products were also generated in cells treated with other proteasome inhibieries of the cell and therefore a possible candidate to generate truncated versions of ubiquitinated proteins tors, such as lactacystin or MG132 (data not shown), but not or only very faintly in DMSO treated samples or due to partial proteolysis. Alternatively, given that htt is a very large protein (350 kDa), other protease(s) might in cells exposed to control inhibitor ALLM, this suggests that a protease acts on htt before its normal clearance act on htt before it enters the core of the proteasome to reduce the size of htt polypeptides that have to be by the proteasome. Given that treatment with proteasome inhibitors led unfolded and degraded. To discriminate between the two scenarios, we examined the role of the ubiquitin/ to an increased frequency of inclusions in htt-expressing cells (data not shown, Jana et al., 2001), we hypotheproteasome pathway in the normal clearance of htt. We coexpressed his-tagged ubiquitin together with htt of sized that these htt breakdown products may correspond to accumulating cp-A and cp-B, respectively. In 502 aa with 15 or 66 Glns (hd15 and hd66, Figure 1A ) or an even shorter htt fragment comprising the first 82 agreement with this hypothesis, we detected these htt breakdown products in the FA-soluble fraction of aa (hd125-82) and recovered ubiquitinated htt by affinity purification on a Nickel column, confirming that soluble T-hd122-expressing cells treated with ALLN ( Figure 4C ). In addition, the htt products seen under proteasome mutant and wild-type htt undergo ubiquitination (see Supplemental Figure S4 analyzed on WB using mAb 1C2 ( Figure 4E, lanes 2-6) . approaches for which we generated several htt versions with C-terminal truncations, internal deletions, or double Self-digestion treatment without protease inhibitors generated major htt fragments similar in size to cp-A amino acid substitutions ( Figure 5A ). Our previous IF study ( Figure 1B ) indicated that site A lies between aa and cp-B. In contrast, htt proteolysis was prevented in the presence of a protease inhibitor cocktail (P.I.C.) 82 and aa 115-129. To locate it more precisely, we used in a first approach truncated mhtt versions of 101 aa (containing aprotinin, antipain, chymostatin, leupeptin, and pepstatin). When these inhibitors were used individand 124 aa (designated hd73-101aa and hd73-124aa in Figure 5A ) as size standards to map the size of cp-A ually, only pepstatin, an inhibitor of aspartic endopeptidases, blocked htt proteolysis ( Figure 4E , and data not produced in ALLN-treated htt-expressing cells. Figure 5C, lower panel) , despite similar expression levels of both constructs in SDS-soluble extract ( Figure  5C, upper panel, lanes 1 and 2, respectively) . Instead, mAb 1C2 detected a faint fragment slightly shorter than cp-A. This shorter fragment was able to form NIs (data not shown) like any other sufficiently small mhtt fragment (Hackam et al., 1998). However, it is noteworthy that a fragment of similar size was seen after expression of another deletion mutant (aa 84-98) (data not shown), suggesting that this smaller breakdown product is most likely generated through a cleavage event in the genetically modified domain and is therefore not of relevance for this study. Nevertheless, the lack of cp-A in longterm cultured NG108 cells is consistent with the data obtained from the proteasome inhibition assay and confirms the importance of domain aa 104-114 in htt proteolysis. Finally, to determine the amino acid residues ., 2000) , the htt breakdown and data not shown), although to a somewhat reduced products involved in the aggregation process have level, suggesting that the tertiary structure of the region is important for cleavage. In addition, similar results never been studied.
Heterogeneity of Nuclear and Cytoplasmic Inclusions
In this study, we focused on the identification of htt fragments present in CIs and NIs, a pathogenic hallmark in HD. We provide evidence that mutant htt fragments of different size, but shorter than the caspase fragments, differentially build up CIs and NIs. Applying immunofluorescence analysis and a disaggregation assay, we demonstrated that a fragment shorter than 115 aa, designated cp-A, and most likely its polyubiquitinated derivatives are the major mhtt-derived components 
